Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Manhattan Bridge Capital | LOAN | 22. nov 2024 | 5.33 | +1.52 |
Manitex International | MNTX | 22. nov 2024 | 5.74 | +0.17 |
Manitowoc | MTW | 22. nov 2024 | 10.81 | +2.27 |
Mannatech | MTEX | 22. nov 2024 | 8.40 | 0.00 |
MannKind | MNKD | 22. nov 2024 | 6.84 | -0.87 |
ManpowerGroup | MAN | 22. nov 2024 | 62.48 | +2.76 |
Manulife Financial | MFC | 22. nov 2024 | 32.47 | -0.64 |
Maplebear | CART | 22. nov 2024 | 43.22 | -0.07 |
Marathon Digital | MARA | 22. nov 2024 | 26.03 | +7.65 |
Marathon Oil | MRO | 22. nov 2024 | 28.55 | 0.00 |
Marathon Petroleum | MPC | 22. nov 2024 | 158.48 | -0.51 |
Maravai LifeSciences A | MRVI | 22. nov 2024 | 5.22 | +5.24 |
Marblegate Acquisition A | GATE | 22. nov 2024 | 11.13 | 0.00 |
Marchex B | MCHX | 22. nov 2024 | 1.65 | -2.94 |
Marcus | MCS | 22. nov 2024 | 22.03 | +0.96 |
Marcus & Millichap | MMI | 22. nov 2024 | 41.20 | +1.53 |
Marex Group | MRX | 22. nov 2024 | 29.18 | -1.65 |
Marin Software | MRIN | 22. nov 2024 | 2.11 | +6.50 |
Marine Petroleum Trust U | MARPS | 22. nov 2024 | 4.06 | +1.54 |
Marine Products | MPX | 22. nov 2024 | 9.98 | +1.42 |
MarineMax | HZO | 22. nov 2024 | 30.56 | +2.86 |
Marinus Pharmaceuticals | MRNS | 22. nov 2024 | 0.33 | +0.84 |
Maris-Tech | MTEK | 22. nov 2024 | 1.71 | -2.29 |
Markel | MKL | 22. nov 2024 | 1 750.00 | +1.84 |
Marker Therapeutics | MRKR | 22. nov 2024 | 3.10 | +5.02 |
Market Vectors Bdc Income ETF | BIZD | 22. nov 2024 | 16.67 | +1.15 |
Market Vectors Investment Grade | FLTR | 22. nov 2024 | 25.50 | +0.04 |
Market Vectors Israel ETF | ISRA | 22. nov 2024 | 42.25 | +0.32 |
Market Vectors Preferred Securi | PFXF | 22. nov 2024 | 18.02 | +0.17 |
MarketAxess | MKTX | 22. nov 2024 | 260.35 | +0.02 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.